Viatris Inc
VTRS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001792044
No open-market purchases or sales by Viatris Inc insiders were filed in the last 90 days; 1,032 institutions reported holding it in 13F filings for Q2 2026, worth $16.6B in total; Greenlight Capital is the only superinvestor holding it.
Q2 2026 vs. Q1 2026
How the institutions holding Viatris Inc changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Of which not filed for Q2 2026 | Q2 2026 | Change |
|---|---|---|---|---|
| Holders | 1,028 | 13 | 1,032 | +17 |
| Shares | 990.9M | 2.15M | 1.05B | +57.0M (+5.8%) |
| Value | $13.4B | $29.0M | $16.6B | +$3.25B (+24.4%) |
13 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (113)
Institutions that held Viatris Inc at the end of Q2 2026 but not at the end of Q1 2026.
Showing the largest 100 of 113 by value.
Sold out (96)
Institutions that held Viatris Inc at the end of Q1 2026 and filed for Q2 2026 without it.
Not filed for Q2 2026 yet (13)
Institutions that held Viatris Inc at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Arcadia Investment Management Corp | 1,329,326 | $18.0M |
| Janus Henderson Group PLC | 527,179 | $7.12M |
| CWM, LLC | 196,990 | $2.66M |
| Skopos Labs, Inc. | 44,515 | $601.4K |
| Journey Strategic Wealth LLC | 17,761 | $239.9K |
| DGS Capital Management, LLC | 12,475 | $168.5K |
| Exencial Wealth Advisors, LLC | 11,557 | $156.1K |
| Evelyn Partners Investment Management Services Ltd | 2,145 | $29.0K |
| Sunbelt Securities, Inc. | 1,842 | $24.9K |
| Evelyn Partners Investment Management LLP | 1,497 | $20.2K |
| McIlrath & Eck, LLC | 862 | $11.6K |
| Financial Connections Group, Inc. | 868 | $11.0K |
| Anfield Capital Management, LLC | 507 | $6.85K |